GlassScriptPhysician profile
Jesse P Garcia
NPI 1124185681
$26,660.77
in general payments reported to CMS, 2019-2025
27 companies · $7,653 in 2025
The $7,653 reported for 2025 was more than what 93% of Surgery providers received nationally (typical 2025 total: $281).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $3,244 · 2020: $1,731 · 2021: $1,298 · 2022: $1,596 · 2023: $6,872 · 2024: $4,267 · 2025: $7,653.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $11K · Food and Beverage: $5,251 · Travel and Lodging: $2,190.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $11,349.84 |
| Food and Beverage | $5,251.35 |
| Travel and Lodging | $2,189.76 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| W. L. Gore & Associates, INC. | $7,211.07 | 2019-2025 | Gore Viabahn Endoprosthesis With Heparin, Gore Viabahn Endoprosthesis, Viabahn Endoprosthesis With Propaten Bioactive Surface |
| Lemaitre Vascular, INC. | $6,148.86 | 2022-2024 | Artegraft Vascular Graft |
| Merit Medical Systems INC | $5,976.73 | 2024-2025 | Wrapsody Stent Graft, Surfacer Inside-Out Catheter, Hero Graft |
| Artegraft INC. | $2,500.00 | 2019-2020 | |
| Bard Peripheral Vascular, INC. | $1,223.53 | 2019-2025 | Lutonix Drug Coated Balloon, Pristine, Denali Vena Cava Filter |
| Inari Medical, INC. | $500.00 | 2021 | |
| Medtronic Vascular, INC. | $495.87 | 2019-2020 | |
| Acera Surgical, INC. | $432.56 | 2024-2025 | Restrata Wound Matrix |
| Becton, Dickinson and Company | $412.89 | 2023-2024 | Pristine, Lutonix Drug Coated Balloon, Covera |
| Medtronic, INC. | $367.05 | 2021-2023 | Hawkone |
| Laminate Medical Technologies INC. | $239.27 | 2024 | |
| Cook Medical LLC | $196.96 | 2021-2025 | Cook, Zilver Vena, Zilver Ptx |
| Osprey Medical INC | $142.00 | 2021 | |
| Venturemed Group, INC. | $135.30 | 2025 | Flex Vessel Prep System |
| Cagent Vascular INC | $127.83 | 2025 | Serrantor |
Show all 27 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Boston Scientific Corporation | $111.91 | 2019-2025 | General - Thrombectomy |
| Shockwave Medical, INC | $80.06 | 2019-2023 | Shockwave Ivl System With The Shockwave C2 Coronary Ivl Catheter |
| Philips North America LLC | $75.67 | 2023 | |
| E.R. Squibb & Sons, L.L.C. | $52.07 | 2019 | |
| Silk Road Medical, INC. | $50.42 | 2021-2023 | Enroute Transcarotid Neuroprotection System, Enroute Transcarotid Stent |
| Penumbra, INC. | $45.71 | 2025 | Penumbra System |
| Astrazeneca Pharmaceuticals LP | $35.32 | 2020-2021 | |
| Abbvie INC. | $24.59 | 2022 | |
| Davol INC. | $24.49 | 2024 | Arista Ah Flexitip |
| Smith+Nephew, INC. | $21.20 | 2021 | |
| Avenu Medical INC. | $14.71 | 2019 | |
| Pfizer INC. | $14.70 | 2019 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Jesse Garcia listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.